In lung cancer, miR-338-5p can inhibit the expression of METTL3, thereby decreasing the m6A modification of c-Myc, down-regulating its expression and inhibiting the proliferation, invasion and migration of lung cancer cells [85]. This evidence concerns the gene METTL3 and lung carcinoma.